NCT04388839 2025-11-26Evolutionary Therapy for RhabdomyosarcomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Active not recruiting12 enrolled
NCT00077285 2025-11-04Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk RhabdomyosarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting65 enrolled